- Home
- EVM vs MRVI Comparison
EVM vs MRVI Comparison
Compare EVM & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVM
- MRVI
- Stock Information
- Founded
- EVM 2002
- MRVI 2014
- Country
- EVM United States
- MRVI United States
- Employees
- EVM N/A
- MRVI N/A
- Industry
- EVM Finance/Investors Services
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- EVM Finance
- MRVI Health Care
- Exchange
- EVM Nasdaq
- MRVI Nasdaq
- Market Cap
- EVM 230.9M
- MRVI 262.9M
- IPO Year
- EVM N/A
- MRVI 2020
- Fundamental
- Price
- EVM $8.78
- MRVI $1.77
- Analyst Decision
- EVM
- MRVI Hold
- Analyst Count
- EVM 0
- MRVI 10
- Target Price
- EVM N/A
- MRVI $7.59
- AVG Volume (30 Days)
- EVM 55.8K
- MRVI 3.3M
- Earning Date
- EVM 01-01-0001
- MRVI 05-07-2025
- Dividend Yield
- EVM 4.01%
- MRVI N/A
- EPS Growth
- EVM N/A
- MRVI N/A
- EPS
- EVM 0.20
- MRVI N/A
- Revenue
- EVM N/A
- MRVI $259,185,000.00
- Revenue This Year
- EVM N/A
- MRVI N/A
- Revenue Next Year
- EVM N/A
- MRVI $14.23
- P/E Ratio
- EVM $47.61
- MRVI N/A
- Revenue Growth
- EVM N/A
- MRVI N/A
- 52 Week Low
- EVM $7.67
- MRVI $1.68
- 52 Week High
- EVM $9.59
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- EVM 35.58
- MRVI 29.16
- Support Level
- EVM $8.49
- MRVI $1.68
- Resistance Level
- EVM $8.86
- MRVI $1.89
- Average True Range (ATR)
- EVM 0.18
- MRVI 0.17
- MACD
- EVM -0.04
- MRVI 0.03
- Stochastic Oscillator
- EVM 25.22
- MRVI 15.56
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.